Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – Kentucky House Passes Medical Cannabis Legalization Bill

On Thursday, the Kentucky House of Representatives passed legislation legalizing medical marijuana within the state.

This comes after the Judiciary Committee voted in the bill last week in a vote of 65-30. The Legislation now proceeds to the state Senate.

If the legislation is enacted into law, patients will be in a position to access medical marijuana from licensed dispensaries, but only after the patients have been certified as suffering from a condition found on the list of qualifying conditions. The legislation would also establish a body to develop rules to govern the program and determine the various medical conditions that individuals would be suffering from to access cannabis.

The legislation would also prohibit smoking of weed and would leave the regulators to decide if they should permit the use of marijuana edibles. A minimum of 25 dispensaries will be allowed to sell medical marijuana, according to the current form of the bill.

The legislation was sponsored by Rep. Jason Nemes (R). In his opening remarks, Nemes said that he is proud to have been involved in the drafting of the tightest medical cannabis bill in the industry. However, he was disappointed by the smoking ban because he believes that smoking is the quickest means of delivery and can be useful for specific ailments.

The legislation has a provision subjecting the gross receipts of marijuana sales from a farmer to processor to dispensary to a 9% tax. Eighty percent of the tax proceeds would be assigned to a general state medical marijuana trust fund, and the remaining 20% would be distributed to regions where marijuana businesses are allowed to operate.

Before approving the legislation, the lawmakers passed several floor amendments, and they include;

That the list of qualifying conditions must consist of at least chronic pain, epilepsy, multiple sclerosis and nausea or vomiting.
Families to return the remaining medical marijuana products to the dispensaries within ten days if the patient has died.
An amendment prohibiting the advertisement of medical marijuana businesses.
Allowing law enforcement to access marijuana sales data from licensed dispensaries
Banning the sale of marijuana vaping products to people under the age of 21.
Prohibiting dentists, podiatrists, and optometrists from prescribing or recommending medical marijuana.
Hospitals to report instances where medical marijuana patients are diagnosed with cannabinoid hyperemesis syndrome.
Prohibiting the sale of medical marijuana to minors and action would be taken against dispensaries that do so.

The chamber rejected a provision that would have increased the penalties for people selling marijuana purchased from the dispensary.

Matt Simon said that patients within Kentucky were relieved after the House approved the bill, but they are aware the legislation will face a considerable amount of challenges in the Senate.

Although a medical marijuana legalization bill was approved by the Judiciary Committee in 2019, it did not receive any floor action. It is uncertain how the current proposal will fare in the Senate, but the Senate President, Robert Strivers (R), agreed that 2020 might be different.

Strivers said that although there is a chance of the bill being approved in the Senate, it is minimal.

Kentucky Governor Andy Beshear (D) is in favor of medical marijuana legalization as it would help fight the opioid crisis.

A poll released last month showed that out of 10 residents of Kentucky, nine were in favor of medical marijuana legalization.

Industry watchers believe that cannabis companies like Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) will be hoping that the lawmakers consider the needs of patients and pass this bill so that another treatment option is available to those who need it.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – New NFL Collective Agreement Could End Player Bans Due to Failed Marijuana Tests

On Thursday, NFL team owners approved a proposed collective bargaining agreement, which ensures that National Football League players would no longer be suspended from games for testing positive for marijuana. The agreement was then circulated to the players.

The new measure being floated for approval by the NFL Players Association would also reduce the number of players being subjected to marijuana testing. It also reduces marijuana and other drugs testing periods. The drug tests can be administered over a period of two weeks at the start of training camp instead of the current two months.

The three-page summary of the policy’s key terms includes an increase in the limit for positive THC metabolite tests from 35 to 150 nanograms.

Darren Heitner was the first to post the policy document on Twitter when he sent all the players a fact sheet covering the highlights of the current proposal for a new collective agreement.

Earlier this month, the details of the reduced penalties for NFL players who test positive for marijuana started in press reports. NBC Sports ProFootballTalk reported that suspensions would only be possible in the event of extreme and recurrent disregard of the policy or violations of the law on possession and consumption of marijuana.

If the NFL Players Association approves the agreement, the NFL would be the latest major sports league to loosen their restrictions on marijuana since the number of states in the U.S. legalizing marijuana is increasing.

In December of 2019, Major League Baseball announced that it would be removing marijuana from the list of banned substances and that it would treat cannabis consumption as alcohol.

In interviews, Jerry Jones, the owner of the Dallas Cowboys, and the New England Patriots quarterback Tom Brady, said that there is a likelihood that the NFL would amend its approach to marijuana on its players after the MLB change was announced.

The terms of the agreements were approved on Thursday by NFL team owners, while player representatives are scheduled to consider it on Friday.

The players association has been holding meetings in the past few weeks to decide if they should proceed with the agreement; however, if they do not make a decision very soon, it will be another year in which the players will be subjected to stringent marijuana policies within the NFL. Two-thirds of the association must approve the measure before March 18 for the policies to be valid for 2020-2021. The new league year begins on March 18.

It is widely believed that these indications that the NFL will ease its stance on marijuana is likely to be welcomed by sector players like MCTC Holdings Inc. (OTC: MCTC) will be pleased by this development since current information shows that marijuana has benefits that weren’t properly known in the past.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Ahead of Curve in China’s CBD Market

ChineseInvestors.com (OTCQB: CIIX) is employing its financial proficiency to establish itself as a leader in China’s emerging cannabidiol (“CBD”) industry. An article discussing the company reads, “Although cannabis is currently illegal in China, hemp-based CBD can be legally added to nutrition and health products and cosmetics, opening up massive opportunities in the untapped Chinese CBD market. CIIX has created a three-year development plan to pioneer an attractive lineup of CBD-based products through its subsidiary, CBD Biotech, and capitalize on the tremendous potential of the enormous Chinese market, where the benefits of CBD oil have not been widely recognized yet. . . . In addition, in a bid to meet growing consumer expectations for seamless digital customer experiences, the company is developing a CBD-focused platform for Chinese people to review and discuss various CBD products. The platform is intended to be a Yelp-style mobile app and will be the first CBD social-media mobile app that caters to Chinese-speaking customers worldwide. The company has already launched another digital product, www.ChineseCBDoil.com, the world’s first online, CBD-infused, health-products store in Chinese.”

To view the full article, visit http://cnw.fm/Ig7A6

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – Undercover Investigators Lead to Administrative Complaints Against Florida Medical Cannabis Doctors

Two medical marijuana doctors are under investigation after Florida health officials filed a complained against them based on information obtained by undercover investigators posing as patients. A lawyer representing one of the doctors termed it as a trap.

The Department of Health in Florida filed both complaints on the same day in 2019, and are waiting for administrative law judges to take action. This is the first significant action taken by Florida against doctors prescribing marijuana to patients.

Tallahassee doctor, Joseph Dorn is one of the doctors being investigated.

The complaint stated that Dorn was the chief medical officer of Medical Marijuana Treatment Clinics of Florida between Feb. 2017 and Jan. 2018. During this period, Dorn issued 3,292 patients with medical marijuana, and each new patient had to pay $299 for the appointment.

Dorn is being accused of failing to conduct physical examinations of ‘Patient O.G’ and ‘Patient B.D,’ which violates medical marijuana laws.

According to the complaint, Dorn failed to do the following;

Did not assess the patients’ medical histories,
Did not diagnose the men with at least one qualifying medical condition
Failed to determine if the use of medical marijuana by the patients would outweigh the potential health risks, and
Did not review the patients’ controlled-drug prescription histories in the state’s database

Dorn is accused of making untrue and fraudulent representations in or related to medicine by recording false details in the men’s’ files to justify entering physician certifications for medical marijuana.

In November of 2017, Patient B.D saw Dorn and complained of muscle spasms and anxiety, but Dorn diagnosed him with post-traumatic stress disorder. Dorn asked the patient if he had been in any car accident, and the patient said he had eight years before the appointment but did not provide details about the severity of the accident. However, in his records, Don wrote that Patient B.D was suffering from PTSD because of trauma from the accident.

Patient O.G reported the second complaint against dorn, and his record shows that he was diagnosed with PTSD. Dorn went on to record a list of symptoms the patient was experiencing, but Patient O.G did not say that he had any symptoms.

Speaking to The News Service of Florida, Dorn’s Lawyer, Robert Beasley, said that the veterans’ group contacted him and stated that Florida health officials were going after doctors who used a PTSD diagnosis when prescribing medical marijuana. Many military veterans have PTSD.

Justin Davis, a Gainesville area doctor, was accused of violating state law by operating his office near the medical marijuana operator Trulieve’s office in Lady Lake. He was also accused of referring patients to Trulieve, as well as failing to determine if Patient K.G was pregnant. Patient K.G was also an undercover agent.

Industry watchers believe that these compliants in Florida are going to be followed closely by the entire marijuana industry, including SinglePoint Inc. (OTCQB: SING), because it may have far-reaching repurcussions on the willingness of doctors to recommend medical marijuana to patients that can be helped.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – The Clergy in Connecticut Advocate for Marijuana Legalization

Church leaders in Connecticut gathered on Tuesday to rally in support for draft legislation seeking to legalize marijuana. The Connecticut Clergy Coalition is backing governor Ned Lamont’s legislation as it would regulate and tax marijuana.

The coalition that represents more than 100 congregations said that marijuana regulation would cut across racial, ethnic, and gender lines.

The Connecticut Clergy Coalition is requesting state lawmakers to back the legislation. The legislation would allow people above the age of 21 to possess and buy a maximum of one and a half ounces of marijuana from a licensed dealer.

The Coalition further saif that they are supporting the legislation as it would allow legitimate businesses to sell marijuana and pay tax; thus, fighting drug dealers and other criminals.

The coalition said that the war against drugs has disproportionately affected people of color, low-income communities, and inner-city residents.

Reverend Stephen Camp from Faith Congregational Church in Hartford said that he is tired of seeing young, black, and brown children having their lives disrupted because the state cannot regulate marijuana.

The bill seeking to legalize recreational marijuana was introduced by Governor Lamont. The governor said that he is working together with the neighboring states such as New York, New Jersey, and Pennsylvania which have taken steps to legalize adult-use marijuana or are considering it.

Lamont further said that it would take a short drive to the border for the residents of Connecticut to buy weed from legal states, or they can buy it from the black market within the state.

In his State of the State address, the governor also said that he considers marijuana legalization as a social justice issue.

Reverend Charlie Stallworth of East End Baptists Tabernacle Church in Bridgeport said that it is high time we stand together and reform the failed marijuana policy. It will help the state to move forward in a way that would help lift our communities.

Republican lawmaker, Vincent Candelora said that he is open to helping people impacted by marijuana-related convictions. He also said that he would allow people to cultivate marijuana at their homes, but he is opposed to regulating marijuana sales.

Candelora further said that when you attach profit to cannabis, that is when young children are going to be preyed on.

The Connecticut Clergy Coalition said that the legislation would allow the police to focus on more severe crimes and enhance community relations.

Now that the clergy has spoken loud and clear in support of marijuana legalization, experts think that cannabis companies like No Borders Inc. (OTC: NBDR) are confident that it is just a matter of time before the necessary legal reforms are passed.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Targets Cannabinoid Extract Industry

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) is a hemp-biomass cultivation, extraction, formulation and refining entity that utilizes its trademarked Delta Reclaiming System technologies to limit CBD waste. A recent article discussing the company reads, “HTC Extraction Systems’ working relationships with other cannabinoid industry players further shore up its revenues possibilities. Most recently, the Canadian company closed its acquisition of a California-based company in the United States. The recently acquired Kase Farma Inc. is authorized to work with hemp cultivation, extraction, refining, formulation and business operations in the world’s largest cannabinoid market (http://cnw.fm/vl8KO), and HTC Extraction will reap the experience of Kase Farma’s former owner, Starling Brands Inc., which remains involved through a management-services agreement for navigating the business and regulatory climates in California. . . . New equipment that will enable Kase Farma to process and distill up to 12,000 pounds a day of dried hemp-biomass that, at an 8% CBD yield, will give over 400,000 grams daily of CBD and a sizable profile during the upcoming cultivation season. New equipment HTC Extraction Systems is installing at its Saskatchewan facilities will similarly allow the company to receive a projected 2 million kg of hemp biomass for extracting CBD full-spectrum oil (‘FSO’) distillate north of the border under a tolling strategy coordinated with highly recognized area farmers.”

To view the full article, visit http://cnw.fm/p3uHi

About HTC Extraction Systems

HTC Extraction Systems has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp-biomass and cannabidiol (“CBD”) industry as well as gas and liquid extraction. HTC’s extraction and purification systems are engineered to large scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced. For more information, visit the company’s website at www.HTCExtraction.com.

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://cnw.fm/HTC

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – MCTC Holdings Inc. (MCTC) Provides Improved CBD-Infusion Method for Single-Serving Coffee Manufacturers

MCTC Holdings (OTC: MCTC), a research and development company deploying new extraction and infusion technologies for the cannabinoid and hemp industries, recently announced production of its new Hemp You Can Feel(TM) Coffee Infusions tablets and powders that enable food and beverage manufacturers to efficiently infuse their products. An article discussing the company reads, “MCTC’s Hemp You Can Feel(TM) Coffee Infusions are available either as a tablet containing cannabinoid infusions that can be added to coffee pods on a customer-customized basis, or as a cannabinoid powder for manufacturers with automated capabilities. . . .‘We are now offering single-serving coffee manufacturers a superior method to infuse products with CBD and other cannabinoids,’ CEO Arman Tabatabaei stated in the announcement (http://cnw.fm/Dv89Z). ‘It is so revolutionary, we have filed two patents: one on the underlying powderization technology and another on the use of solid and powdered dosing forms for cannabinoids in single-serving beverage pods. With our new products . . . even the smallest of single-serving pod manufacturers will be able to easily transform ordinary, low-margin products into products that are high margin and very profitable.’”

To view the full article, visit http://cnw.fm/y5CN0

About MCTC Holdings Inc.

MCTC Holdings (d/b/a: Cannabis Global) is a Delaware-registered, fully reporting and audited, publicly traded company. With the hemp and cannabis industries moving quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, and the bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. MCTC was reorganized in June 2019 and announced its intent to enter the fast-growing cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Provides Company Update on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives that offer insights into various companies and their operations and future outlooks. This week’s program featured CIIX CEO Warren Wang as he provided a company update, discussing a potential new product line via the company’s subsidiary, CBD Biotech, as well as focus on the company’s core business, financial media broadcasting. “I see a lot of momentum, especially option trading,” Wang stated in the interview, discussing the launch of a new podcast and plans to launch a new website with new membership and a potential added revenue stream.

To view the full press release, visit http://cnw.fm/i7V5R

About ChineseInvestors.com Inc.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Revenue Numbers on MoneyTV with Donald Baillargeon

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht reviewed the company’s revenue numbers, reiterating, from a recent press release, that its revenues were up 190% from last year. “Again, this company is definitely going in the right direction as far as revenues and profit,” Lambrecht said. “This year [2020], the sky’s the limit. I don’t want to predict anything right now, but we’re optimistic we can do over $10 million.”

To view the full press release, visit http://cnw.fm/Nxq6k

About SinglePoint, Inc.

Founded in 2011 SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Medical Marijuana Allows ADHD Patients to Take Fewer Prescription Drugs

A new study has found that people with ADHD (attention-deficit hyperactivity disorder) tend to use less prescription drugs, which are powerful, addictive, and psychostimulants when they consume more medical marijuana.

The researchers found that patients who consumed medical marijuana compounds, such as cannabinoids and terpenes, reported a higher occurrence of stopping usage of all ADHD medication. The study findings were published in the Rambam Maimonides Medical Journal last month.

The researchers said that in the study, they demonstrated how ADHD patients treated using medical marijuana stopped using their prescription medication, especially those who consumed medical marijuana in high doses.

The best results were realized when patients used the cannabinoid CBN (cannabinol), which is found in a small amount in select marijuana plants. The researchers further stated that more research is required to fully understand if marijuana and its compounds can be used for treating ADHD.

The researchers also concluded that although the results are not causal, they may shed light on the potential benefits of medical marijuana on ADHD symptoms. And this could motivate scientists to investigate further to endorse the study results. And maybe, cannabis could be approved as a treatment for ADHD in states where marijuana is legal.

The study respondents consisted of 53 medical marijuana patients from Isreal who were in the database of people who had previously agreed to participate in the study. The patients were also diagnosed with ADHD. Out of the 53 patients, 37 of them were suffering from a mental health condition in addition to ADHD.

The study respondents were asked to report monthly on an individual basis of the method of marijuana consumption, the manufacturer, and marijuana strain name between the month of October 2019 and January 2020.

They found that higher doses of marijuana compounds (Phyto-cannabinoids and terpenes) helped the patients reduce the ADHD prescription drugs they used.

The researchers further wrote that previous studies on ADHD and marijuana ignored the inherent complexities and variability between marijuana strains and a combination of cultivars; instead, they viewed marijuana as a single product.

Most of the ADHD patients in the study obtained medical marijuana cards for chronic pain or cancer treatment instead of neurological disorders.

The study, which was funded by the Evelyn Gruss Lipper Charitable Foundation, found that 47 patients consumed marijuana through smoking or vaporization.

The study divided the consumers into high and low doses. There were 27 different combinations of marijuana strains, and apart from CBN, THC, THCV, and CBD were also found to reduce the consumption of prescription medications among ADHD patients.

Industry watchers say that cannabis companies like ChineseInvestors.com Inc. (OTCQB: CIIX) expect even more studies to prove many of the other health benefits that have been linked to cannabis.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.